ࡱ> i RbjbjڲڲH؏\؏\=!Byyyyy8l1( ^``````$1"$@yyyMyy^^PYsCJc0'%&'%'%y4'%I ?: DN Sf[N6RoSk6RBRvU_,{]NASNyb ^SoT(u Tye Tĉy*gۏSSxoTe,g N^97-3vxeYf^[mBROxybutynin hydrochloride/APOHIDE Lotion 20%20%4.5ml:0.9ml ENIQ6Ro*h_O>y*gۏSSxoTe,g N^97-42uxx~0W[GrNaldemedine Tosylate Tablets/00000000.2mgN~0W[ iXΑ*h_O>y*gۏSSxoTe,g N^97-5[lxk"}m\S gnmBisoprolol fumarate oral solution1mg/mlAspire Pharma Limited*gۏSSxoTV N^97-6m^xOb^GrBempedoic Acid and Ezetimibe Tablets / Nustendi180mg/10mgDaiichi Sankyo Europe GmbH*gۏSSxoT'kv N^97-14-N'`ygmsNxv Balance 1.5% Glucose,1.75 Mmol/L Calcium Solution For Peritoneal Dialysis+T1.5%a|3L/ Fresenius Medical Care Deutschland GmbH*gۏSSxoT'kv N^97-15-N'`ygmsNxv Balance 2.3% Glucose,1.75 Mmol/L Calcium Solution For Peritoneal Dialysis+T2.3%a|3L/ Fresenius Medical Care Deutschland GmbH*gۏSSxoT'kv N^97-16-N'`ygmsNxv Balance 4.25% Glucose,1.75 Mmol/L Calcium Solution For Peritoneal Dialysis+T4.25%a|3L/ Fresenius Medical Care Deutschland GmbH*gۏSSxoT'kv N^97-17-N'`NOygmsNxv Balance 1.5% Glucose,1.25 Mmol/L Calcium Solution For Peritoneal Dialysis+T1.5%a|3L/ Fresenius Medical Care Deutschland GmbH*gۏSSxoT'kv N^97-18-N'`NOygmsNxv Balance 2.3% Glucose,1.25 Mmol/L Calcium Solution For Peritoneal Dialysis+T2.3%a|3L/ Fresenius Medical Care Deutschland GmbH*gۏSSxoT'kv N^97-19-N'`NOygmsNxv Balance 4.25% Glucose,1.25 Mmol/L Calcium Solution For Peritoneal Dialysis+T4.25%a|3L/ Fresenius Medical Care Deutschland GmbH*gۏSSxoT'kv N^97-20KQ U4SGrClotrimazole Vaginal Tablets0.5gBAYER HEALTHCARE SAS/BAYER SA-NV*gۏSSxoT'kv N^97-21ZTGrParacetamol and Caffeine Tablets /Panadol ExtraFUT T:N Solpadeine HeadachevNS[YNp(lWZ500mgTaUV65mgHaleon Ireland Limited*gۏSSxoT'kv N^97-22XNxQAzelaic Acid Gel/Finacea15%LEO Laboratories Limited*gۏSSxoTV N^97-23m^l(lN Nny*gۏSSxoTe,g N^97-25xpQ^tʑl\mEQ_ Lanreotide Acetate Sustained-release Injection (a pre-filled syringe) /SOMATULINE DEPOTEQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML)Ipsen Pharma Biotech SAS*gۏSSxoTVYjvfN97-26xpQ^tʑl\mEQ_ Lanreotide Acetate Sustained-release Injection (a pre-filled syringe) /SOMATULINE DEPOTEQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML)Ipsen Pharma Biotech SAS*gۏSSxoTVYjvfN97-27xpQ^tʑl\mEQ_ Lanreotide Acetate Sustained-release Injection (a pre-filled syringe) /SOMATULINE DEPOTEQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML)Ipsen Pharma Biotech SAS*gۏSSxoTVYjvfN97-28̖NQEstradiol Gel/DIVIGEL0.10%Vertical Pharmaceuticals, LLC*gۏSSxoTVYjvfN97-29xxSf<\GrRuxolitinib Phosphate Tablets/JAKAFI5mgINCYTE CORP*gۏSSxoTVYjvfN97-30xxSf<\GrRuxolitinib Phosphate Tablets/JAKAFI15mgINCYTE CORP*gۏSSxoTVYjvfN97-31xxSf<\GrRuxolitinib Phosphate Tablets/JAKAFI20mgINCYTE CORP*gۏSSxoTVYjvfN97-32g|jx*Y<\l\mFentanyl Citrate Injection/FENTANYL CITRATE0.05mg/mLAkorn Inc/HIKMA Inc*gۏSSxoTVYjvfN97-33RwxU!TfWGrZolpidem Tartrate Tablets/AMBIEN10mgCosette Pharmaceuticals Inc*gۏSSxoTVYjvfN10-64RwxU!TfWGrZolpidem Tartrate Tablets/AMBIEN5mgSANOFI AVENTIS US LLC/Cosette Pharmaceuticals Inc*gۏSSxoTXRSfT N^Sc gNCosette Pharmaceuticals Inc5-41vx_GrMexiletine Hydrochloride Tablets50mgKYOWA CritiCare Co., Ltd/00000000*h_O>ye,g N^XRSfT N^Sc gN00000000*h_O>y23-68046DFLNRTZ\bdjnvx          n зззззззuuuun hCJo(hB*CJH*KHPJphhCJPJhB*CJPJphhB*CJKHPJphhB*CJKHPJo(ph0h5B*CJKHOJPJQJ\^Jo(ph)h5B*CJOJPJQJ^Jo(phhCJ,PJaJ,o(hCJ OJPJQJaJ o(*.06@FNT\dl $$Ifa$$If$G$a$ PdgdKH lnxMG:, $$7$8$H$Ifa$ $$1$9DIfa$$Ifkd$$IfT44֞ey .(029KfJJ944 laf4T n $$1$9DIfa$ $$7$8$H$Ifa$   OI<<<< $$1$9DIfa$$Ifkd$$IfT4֞ey .(029KfJJ944 laf4T       ( * 2 6 > @ P R     R ` b l | ~  ȱȱ޸ޱ *h7B*CJPJph hCJo(hB*CJKHPJo(phhCJPJhB*CJKHPJphhB*CJPJphhB*CJKHPJo(ph hCJ= * 4 6 @ R B<$Ifkd$$IfT4֞ey .(029KfJJ944 laf4T $$1$9DIfa$  B<$IfkdY$$IfT4֞ey .(029KfJJ944 laf4T $$1$9DIfa$  b ~ Bkd3$$IfT4֞ey .(029KfJJ944 laf4T $$1$9DIfa$  " N ^ h $$1$9DIfa$$If  " L N \ ^ f j r t " $ 2 4 < @ H J V X hjrthB*CJPJphhCJPJ hCJ hCJo( *h7B*CJPJphhB*CJKHPJo(ph *h7B*CJPJph"""hB*CJKHPJph! *h7B*CJKHPJph9h j t $ OI<<<< $$1$9DIfa$$Ifkd $$IfT4֞ey .(029KfJJ944 laf4T$ 4 > @ J X B<$Ifkd$$IfT4֞ey .(029KfJJ944 laf4T $$1$9DIfa$ B<$Ifkd$$IfT4֞ey .(029KfJJ944 laf4T $$1$9DIfa$bBkd$$IfT4֞ey .(029KfJJ944 laf4T $$1$9DIfa$jl~02FH|fxz $0248:>@BDFHJLNbtv~ֳȳȳֳֳֳȳȣȣȣȣȳֳhB*CJH*KHPJph(hB*CJPJfH phq hB*CJKHPJphhB*CJKHPJo(ph hCJ hCJo(hB*CJPJph@  $$Ifa$$If2H|OI@@@@@ $$Ifa$$Ifkdu$$IfT4֞ey .(029KfJJ944 laf4T2fF@$IfkdO$$IfT4֞ey .(029KfJJ944 laf4T $$Ifa$fzNF@$Ifkd) $$IfT4֞ey .(029KfJJ944 laf4T $$Ifa$NbvF@$Ifkd $$IfT4֞ey .(029KfJJ944 laf4T $$Ifa$~N\^fjtv$&.6<@$&hjrzjl,.6:DFbdθάάάάάάάθhB*CJPJphhCJPJhB*CJKHPJphhB*CJKHPJo(ph hCJ hCJo((hB*CJPJfH phq DN^hjvF@$Ifkd $$IfT4֞ey .(029KfJJ944 laf4T $$Ifa$$BF@$Ifkd $$IfT4֞ey .(029KfJJ944 laf4T $$Ifa$hFkd $$IfT4֞ey .(029KfJJ944 laf4T $$Ifa$.8 $$Ifa$$If8:FdfvOI@@@@@ $$Ifa$$Ifkdk $$IfT4֞ey .(029KfJJ944 laf4T ftv~@BJRX\^FH  ".0DLtz|ɳֳֳֳhB*CJPJo(phhCJPJ hCJ hCJo(hB*CJPJphhB*CJKHPJphhB*CJKHPJo(phFv@^F@$IfkdE$$IfT4֞ey .(029KfJJ944 laf4T $$Ifa$F@5 $$1$Ifa$$Ifkd$$IfT4֞ey .(029KfJJ944 laf4T $$Ifa$ "0F@$Ifkd$$IfT4֞ey .(029KfJJ944 laf4T $$Ifa$0jt|8@r FfFf$IfFf4 $$Ifa$r^lnvz"$,0:<Z """$"("2"4"R"#####ʺʺʺ庚ʺʺʺhB*CJKHPJo(phh>*B*CJKHPJphhB*CJKHPJo(ph hCJ hCJo(hB*CJPJo(phhB*CJKHPJphhB*CJPJph<^nxz$.0<\ \ !! ""Ffi#Ff$IfFf $$Ifa$"&"("4"T"#X#########4$D$P$R$^$n$$$$$$Ff-FfK*$IfFf& $$Ifa$####4$B$D$N$R$\$^$l$n$$$$$$%%%%~%%%%%%%%%$&2&4&>&B&L&N&`&b&&''''' '.''''''''(((())))))))))))*zԶUhB*CJKHPJo(phhB*CJPJphhB*CJKHPJphhB*CJKHPJo(ph hCJ hCJo(H$$%%\%f%~%%%%%%& &$&4&@&B&N&b&&&&'''Ff;Ff8Ff4 $$Ifa$$IfFf-1' '0'r'|'''''''0(8((((Ff> $$Ifa$$If(())X)b))))OFFFFFFF $$Ifa$kd@$$IfT4֞ey .(029KfJJ944 laf4T))*zFz`zzz{OFFFFFFF $$Ifa$kdA$$IfT4֞ey .(029KfJJ944 laf4Ts|0W\=dBRMinoxidil Liniment/ ROGAINE5% W/V60ml Johnson And Johnson Group Consumer Companies/KENVUE BRANDS LLC*gۏSSxoTXRcFU/KENVUE BRANDS LLC24-70s|0W\=dBRMinoxidil Liniment/ ROGAINE2% w/v60ml Johnson And Johnson Group Consumer Companies/KENVUE BRANDS LLC*gۏSSxoTXRSfT N^Sc gNKENVUE BRANDS LLC29-126|xs|~gsNMometasone Furoate Cream/ Elocon0.1%b1mg/g(Sňĉy/*h_O>y000000*gۏSSxoTXRSfT N^SN*h_O>y00000091-50 Nz }l\mꁨRl\hV Epinephrine Injection/EpiPen0.3mgMylan Healthcare B.V./Mylan Products Ltd.*gۏSSxoTXR N^Sc gNMylan Products Ltd.91-51 Nz }l\mꁨRl\hV Epinephrine Injection/EpiPen junior0.15mgMylan Healthcare B.V./Mylan Products Ltd.*gۏSSxoTXR N^Sc gNMylan Products Ltd.92-10U<\lVZonisamide Capsules/ Zonegran100mgConcordia Pharmaceuticals Inc/ADVANZ PHARMAUS)CORP*gۏSSxoTXRSfT N^Sc gNADVANZ PHARMAUS)CORP10-239^Xegf^VCelecoxib Capsules/Celebrex0.2gG.D.Searle LLC/Upjohn US 2 LLC/Vf6Ro'Yޏ gPlQSVQ N^SxoXRSx0WNS N^Sc gNVf6Ro'Yޏ gPlQS4-27^tON@lGrRosuvastatin Calcium Tables/CrestorS[ 5mg cC22H28FN3O6S Astrazeneca UK LimitedSxۏSXR-NeFUT TS[ ~NRP[_4-28^tON@lGrRosuvastatin Calcium Tables/CrestorS[ 10mg cC22H28FN3O6S Astrazeneca UK LimitedSxۏSXR-NeFUT TS[ ~NRP[_4-29^tON@lGrRosuvastatin Calcium Tables/CrestorS[ 20mg cC22H28FN3O6S Astrazeneca UK LimitedSxۏSXR-NeFUT TS[ ~NRP[_22-123^XxNl\mGadoxetic Acid Disodium Injection/Primovistnf>f 10ml:1.8143g c^XxN Bayer Vital GmbHVQ N^vSxoTfeĉe\'`oir N TNnfSf[oir wQ gN[vyrk'`Y>e\'`0eHe'`0 c>e\'`;m^~oI{yrp Sk6RBR;N(uNfnxvQxSvhTW,gBl S9hncvQoiryr'` Te~TSk6RBRvS_'`ۏLxvz0       PAGE 10   PAGE \* MERGEFORMAT11   z zRzTz\z^zzzzz,{8{~{{{{ |||2|f|t|||||||||||||}}}}}~~~~~8H@\^dnpr||΁ځ΂ЂR^҄ ~hCJPJo(hCJPJhB*CJKHPJphhB*CJKHPJo(phR{ {,{:{r{{ ||V|OFFFFFFF $$Ifa$kdB$$IfT4֞ey .(029KfJJ944 laf4TV|X|f|v|||}}}OFFFFFFF $$Ifa$kdWC$$IfT4֞ey .(029KfJJ944 laf4T}}}~l~~~~*OFFFFFFF $$Ifa$kd#D$$IfT4֞ey .(029KfJJ944 laf4T*,8J>OFFFFFFF $$Ifa$kdD$$IfT4}֞ey .(029KfJJ944 laf4T>@N2|OFFFFFFF $$Ifa$kdE$$IfT4\֞ey .(029KfJJ944 laf4T΁܁6@ЂDOFFFFFFF $$Ifa$kdF$$IfT4֞ey .(029KfJJ944 laf4TDFR`OFFFFFFF $$Ifa$kdSG$$IfT49 ֞ey .(029KfJJ944 laf4T"~OFFFFFFF $$Ifa$kdH$$IfT4֞ey .(029KfJJ944 laf4TΆ^`xz|އ ȈƉԉ։*ʊ̊܊ @L΋,:H&4|hCJH*PJhCJPJo(hCJPJo(hCJPJW†ΆR| FRdrƉ։FfTFfQFfM $$Ifa$FfDJ,ht܊02@FkdV$$IfT4֞ey .(029KfJJ944 laf4T $$Ifa$@N.0:FkdOW$$IfT4֞ey .(029KfJJ944 laf4T $$Ifa$:JŒ&6 &vΎ؎|Ffl`Ff\FfY $$Ifa$$lt~Ύ֎؎pzʏ܏ޏ$:(*Dڑj|~>HPRTXZ^`bdfhlړ\`hCJOJPJQJ^JhCJOJPJQJ^JhCJH*PJhCJPJhCJPJo(O|ʏޏ$<*j~Ԓ֒J $d$Ifa$Ff]j $d$Ifa$FffFfc $$Ifa$JnړRt PvrFftFf?qFfm $d$Ifa$`prД \`rtҕrtz2dp 24N̘Ҙ"PVtxz|ӽh0JB*CJaJo(phhdljhdlUhKHho(hB*CJPJo(phhB*CJPJphhB*CJKHPJo(phhCJPJo(hCJPJ=XZdr 4~ΘRv $d$Ifa$ $d$G$Ifa$ d$IfFf{Ff!x $d$Ifa$vxz~}h]h&`#$gdKHkkd}$$IfT40e29K< 944 laf4pT ɈhKHho(hdlhB*CJaJo(ph#hzhzCJaJmHnHsHuhCJaJjhCJUaJhCJaJo(hhz0JCJaJmHnHuh0JCJaJjh0JCJUaJh0JCJaJo(gdKH$4$a$F0P182P0:pzA .!"#$%Sn Dp$$If!vh#v#v#v #v #v #vO#vU:V 449,5K5f5J555/ /  / af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ /  / af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / / /  af4T_$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ /  / af4pFTkd$$IfT4֞ey .(029KfJJ F944 laf4pFTm$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ / / /  af4pFTkd6$$IfT4֞ey .(029KfJJ F944 laf4pFTm$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ / / /  af4pFTkd$$IfT4֞ey .(029KfJJ F944 laf4pFTm$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ / / /  af4pFTkd$$IfT4֞ey .(029KfJJ F944 laf4pFTm$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ / / /  af4pFTkd$$IfT4֞ey .(029KfJJ F944 laf4pFTm$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ / / /  af4pFTkd!$$IfT4֞ey .(029KfJJ F944 laf4pFTm$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ / / /  af4pFTkdk%$$IfT4֞ey .(029KfJJ F944 laf4pFTm$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ / / /  af4pFTkd($$IfT4֞ey .(029KfJJ F944 laf4pFTm$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ / / /  af4pFTkdM,$$IfT4֞ey .(029KfJJ F944 laf4pFTm$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ / / /  af4pFTkd/$$IfT4֞ey .(029KfJJ F944 laf4pFTm$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ / / /  af4pFTkd/3$$IfT4֞ey .(029KfJJ F944 laf4pFTm$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ / / /  af4pFTkd6$$IfT4֞ey .(029KfJJ F944 laf4pFTm$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ / / /  af4pFTkd:$$IfT4֞ey .(029KfJJ F944 laf4pFTm$$If!vh#v#v#v #v #v #vO#vU:V 48 F9,5K5f5J555/ / / /  af4pFTkd=$$IfT48֞ey .(029KfJJ F944 laf4pFT$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 4}9,5K5f5J555/ / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 4\9,5K5f5J555/ / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49 9,5K5f5J555/ / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / /  af4TW$$If!vh#v#v#v #v #v #vO#vU:V 4 <9,5K5f5J555/ / / /  af4p<TkdH$$IfT4֞ey .(029KfJJ <944 laf4p<Tm$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ / / /  af4pFTkd0L$$IfT4֞ey .(029KfJJ F944 laf4pFTm$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ / / /  af4pFTkdO$$IfT4֞ey .(029KfJJ F944 laf4pFTm$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ / / /  af4pFTkdS$$IfT4֞ey .(029KfJJ F944 laf4pFT$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / /  af4T$$If!vh#v#v#v #v #v #vO#vU:V 49,5K5f5J555/ / / /  af4Tm$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ / / /  af4pFTkdX$$IfT4֞ey .(029KfJJ F944 laf4pFTm$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ / / /  af4pFTkd[$$IfT4֞ey .(029KfJJ F944 laf4pFTm$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ / / /  af4pFTkd^$$IfT4֞ey .(029KfJJ F944 laf4pFTC$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ af4pFTkdnb$$IfT4֞ey .(029KfJJ F944 laf4pFTC$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ af4pFTkde$$IfT4֞ey .(029KfJJ F944 laf4pFT_$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ /  / af4pFTkdh$$IfT4֞ey .(029KfJJ F944 laf4pFTm$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ / / /  af4pFTkd_l$$IfT4֞ey .(029KfJJ F944 laf4pFTm$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ / / /  af4pFTkdo$$IfT4֞ey .(029KfJJ F944 laf4pFTm$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ / / /  af4pFTkdAs$$IfT4֞ey .(029KfJJ F944 laf4pFTm$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,5K5f5J555/ / / /  af4pFTkdv$$IfT4֞ey .(029KfJJ F944 laf4pFTs$$If!vh#v#v#v #v #v #vO#vU:V 4 F9,,5K5f5J555/ / / /  af4pFTkd#z$$IfT4֞ey .(029KfJJ F944 laf4pFT$$If!vh#v#v5:V 4 9,5K5</ /  / af4pT s 8 66 666668 0@P`p6888 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ OJ PJ QJ _HmH nHsH tHR`R cke $1$a$(CJKHOJQJ_HaJmH nHsH tH$A $ ؞k=W[SONi@N nfh-\".B-?7}>FTlon77Ԝx?|+NST2 XiEꭶ?j]m^_^+P[wD+PW-W_YW ͶW5 R ~,VAFXuVKsKTCV]rŦZ-t  ;b6#42% qv8›q. B˟TDFLڐAB&~ ^] ُ=q==~NV;(VG:=ՃxiJ!x?>~?< }a\G5TLx?y;~nьHbwc:EGP~Ds |w<4rg!Rt|+c m߆6Il!Q] sZ;aQITjYV`<$6D='Ienb~k3MHýS^P\wr^+j~k~vt~t«(:zQk_۶sWb/?ѹS)uzݜnrʵ+Am~޽: 5ˁWrbJAүsUTjzf5η1T>汀*^PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!.theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] !/ AAAD  ~#z`$*058NW\_bl   h $ fN8v0"$'(){V|}*>D@:|Jv !"#%&'()+,-./1234679:;<OPQRSTUVXYZ[]^`ac"8;D!!8@0(  B S  ? RANGE!O354!!F{{{||33441BLLMM^'??@@Q!IUUVV]Wg 3GE U } > R  y . \  !1]N}0o}@o' `U]?g)S:n%M};l} 5z C ?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdfghijklmnopqrstuvwxyz{|}~Root Entry FfsCData eO~1Table'%WordDocumentHSummaryInformation(DocumentSummaryInformation8CompObjn  FMicrosoft Word 97-2003 ĵ MSWordDocWord.Document.89q